Oncology Competitive Landscape, April 2020: Searching for White Space
Oncology, Competitive Landscape, Clinical Development
It is always a challenge to prioritize indications with an oncology asset. Most drug candidates have multiple applications across a wide set of malignancies and a complex set of competition with an overwhelming competitive landscape with thousands of trials.
To assist in this process, First Principles created a framework to analyze 21 solid tumors and hematologic malignancies, which can also easily integrate any company's technology into its rubric to determine the best white spaces for development.
This report is valuable in its own right, providing insight on the slivers of white space in the oncology therapeutic area, and also as a missing link for any firm that wants to analyze the oncology market, in order to prioritize its clinical research rigorously.
Visit the link below to download an 8-page summary of the paper with abstract, methodology, table of contents. The price is $2,500 to purchase the full report.
Download White Paper
You'll receive communications from First Principles Advisory periodically
Error. Please check your email and try again later.
Case Study: Immuno-oncology competitive intelligence
Case Study: Landscape assessment, development opportunities, and forecasting for novel prostate cancer molecule
Case Study: Portfolio planning and management